VITAS® Healthcare Names Four Leaders to Its Executive Team: Melad, Escueta, Dr. Loftis, Durkin [Yahoo! Finance]
Chemed Corp (CHE)
Last chemed corp earnings: 4/28 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
ir.chemed.com/investor-overview
Company Research
Source: Yahoo! Finance
the promotions of Jennifer Melad, Martin Escueta and Lauren Loftis, MD. The hospice company also welcomes Vicky Durkin as its latest newly hired executive. A Media Snippet accompanying this announcement is available by clicking on this link. As the nation's leading end-of-life care provider and a globally recognized best-in-class employer , VITAS is dedicated to excellence in leadership and service delivery, ensuring that patients and their families receive the highest quality of care, while employees benefit from an engaging and fulfilling career. These appointments follow several recent promotions at VITAS for two key operations executives and a new executive vice president role , as well as two senior vice presidents and four vice presidents in Florida JENNIFER MELAD, VP OF HOSPICE OPERATIONS Overseeing the operations of six VITAS service areas in Southern California, Jennifer Melad ensures the delivery of compassionate care to patients and their families across Orange Co
Show less
Read more
Impact Snapshot
Event Time:
CHE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CHE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CHE alerts
High impacting Chemed Corp news events
Weekly update
A roundup of the hottest topics
CHE
News
- The Family Of Scandal-Plagued Matt Gaetz Controls A Florida Real Estate Empire. Here's What's Inside [Forbes]Forbes
- Chemed Corporation to Present at the Jefferies 2024 Global Healthcare ConferenceBusiness Wire
- Chemed (CHE) Down 3.1% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Chemed Co. (NYSE: CHE) had its price target lowered by analysts at Royal Bank of Canada from $712.00 to $697.00. They now have an "outperform" rating on the stock.MarketBeat
- Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly DividendBusiness Wire
CHE
Earnings
- 4/24/24 - Beat
CHE
Sec Filings
- 6/26/24 - Form 11-K
- 6/13/24 - Form 4
- 6/12/24 - Form 144
- CHE's page on the SEC website